ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...
CK0804 is a first in class, CXCR4hi Treg therapeutic designed to preferentially traffic towards its ligand CXCL12 over ...
Stocktwits on MSN
IBRX garners retail attention on positive update in immunotherapy for lung cancer patients
The company said that responding patients lived longer overall, with a median survival of 16.2 months. ・The data come from ...
ImmunityBio, Inc. ( IBRX) 44th Annual J.P. Morgan Healthcare Conference January 11, 2026 7:00 PM EST ...
Implementing Deep Inspiration Breath-Hold (DIBH) for Left-Sided Breast Cancer Radiotherapy at the Anbar Cancer Center, Iraq: ...
Blood eosinophil count at a specific threshold shows high sensitivity and specificity for diagnosing eosinophilic ...
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
Add Yahoo as a preferred source to see more of our stories on Google. AUSTIN (KXAN) — Sneezing and sniffling this weekend? You aren’t alone. The cedar count has rapidly risen this past week, with a ...
The Allahabad high court has held that a candidate placed on a waiting list has no absolute right to appointment and that a waiting list cannot be in existence for an indefinite period. The court held ...
AUSTIN (KXAN) — Sneezing and sniffling this weekend? You aren’t alone. The cedar count has rapidly risen this past week, with a “very high” count in the Austin area on Saturday. CHECK: Allergy Report: ...
ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug ...
Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback